← Evidence map

ReviewFrontiers in pharmacology2021

Potential Role for Combined Subtype-Selective Targeting of M

Mazen Tolaymat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

12 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34803723